Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism.
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism.
Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron. 2004 Jul 22; 43(2):169-75.
View in:
PubMed
subject areas
Amino Acid Sequence
Cell Line
Dystonia
Humans
Molecular Conformation
Mutation, Missense
Parkinsonian Disorders
Sodium-Potassium-Exchanging ATPase
Structure-Activity Relationship
authors with profiles
William B. Dobyns